Structured exercise programmes after curative treatment
A supervised, coached exercise programme for three years after bowel cancer treatment cut recurrence and death in a large randomised trial. It is the first lifestyle intervention proven to work like an adjuvant drug.
The CHALLENGE trial (CCTG CO.21, NEJM 2025) randomised 889 patients with resected stage III or high-risk stage II colon cancer after adjuvant chemotherapy to a three-year structured exercise programme with behavioural support, or health-education materials. Disease-free survival improved (5-year 80.3% vs 73.9%, HR 0.72) and so did overall survival (8-year 90.3% vs 83.2%, HR 0.63). The target was an increase of about 10 MET-hours per week, roughly 45 minutes of brisk walking most days. This is level-1 evidence in one disease; whether it generalises to breast, prostate and lung cancer is being tested, and the delivery model (physical activity consultants, supervised sessions tapering over years) is the implementation problem.
How it works
Regular aerobic activity lowers circulating insulin, IGF-1 and inflammatory cytokines, improves body composition and immune surveillance, and may reduce the fitness of dormant disseminated tumour cells. Behavioural coaching sustains adherence long enough for these to matter.
- Randomised evidence of a survival benefit with an effect size comparable to adjuvant drugs
- Cheap, safe, and improves fatigue, fitness and quality of life whatever the cancer effect
- Cardiac rehabilitation shows the delivery model can be funded at scale
- Proven so far in one cancer and one trial; replication is needed
- Adherence falls over years without coaching
- Almost no health system reimburses a supervised programme
Latest papers
topQuery for this technology: (TITLE:"Structured exercise programmes after curative treatment" OR ABSTRACT:"Structured exercise programmes after curative treatment") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Structured exercise programmes after curative treatment, not a curated reading list.
Pages like this
not linked directly; found by shared links- TechnologySleep and circadian interventions in cancer
Shares Treat insomnia in survivors and measure whether the cancer notices, Survivorship care and late-effects surveillance, Exercise & lifestyle oncology, Survivorship and late effects are neglected.
- TrialBWEL (Breast Cancer Weight Loss, Alliance A011401)
Shares Energy balance, Dietitian-led weight-loss programmes in HR-positive breast cancer, Obesity-related cancers (IARC list of 13), Exercise & lifestyle oncology.
- Key paperCHALLENGE: a structured exercise programme after chemotherapy improves survival in colon cancer
Shares Pay for supervised exercise the way we pay for drugs, Structured exercise prescribed like a drug in all curative-intent cancer care, Exercise & lifestyle oncology, Survivorship and late effects are neglected.
- TrialWHEL (Women's Healthy Eating and Living)
Shares Time-restricted eating in cancer prevention and survivorship, Energy balance, Dietitian-led weight-loss programmes in HR-positive breast cancer, Survivorship and late effects are neglected.
- TechnologyGLP-1 receptor agonists and obesity-related cancer risk
Shares Metabolic syndrome and insulin resistance, Energy balance, Dietitian-led weight-loss programmes in HR-positive breast cancer, Obesity-related cancers (IARC list of 13).
- PathwayLipid synthesis, uptake & cholesterol
Shares Metabolic syndrome and insulin resistance, Energy balance, Dietitian-led weight-loss programmes in HR-positive breast cancer, Obesity-related cancers (IARC list of 13).
- TermGlycaemic index and glycaemic load
Shares Time-restricted eating in cancer prevention and survivorship, Metabolic syndrome and insulin resistance, Energy balance, Colorectal cancer.
- IdeaGLP-1 receptor agonists as adjuvant weight-loss therapy in HR-positive breast cancer
Shares Energy balance, Dietitian-led weight-loss programmes in HR-positive breast cancer, Obesity-related cancers (IARC list of 13), Survivorship and late effects are neglected.